LSL Pharma Group Announces Voting Results of Its Annual and Special Meeting of Shareholders
June 28, 2024 17:37 ET
|
LSL Pharma Group Inc.
BOUCHERVILLE, Québec, June 28, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL, LSL.DB) (“the Company” or “LSL Pharma”), a Canadian integrated pharmaceutical company, is pleased to...
LSL Pharma Group Secures $1.5 Million as the First Closing of Its Non-Brokered Private Placement
June 27, 2024 10:27 ET
|
LSL Pharma Group Inc.
BOUCHERVILLE, Quebec, June 27, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL, LSL.DB) (the "Corporation" or "LSL Pharma"), a Canadian integrated pharmaceutical company, announced that it...
LSL Pharma Group Completes the Acquisition of Virage Santé
June 18, 2024 07:00 ET
|
LSL Pharma Group Inc.
BOUCHERVILLE, Québec, June 18, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL) ("the Company" or "LSL Pharma"), a Canadian integrated pharmaceutical company, is pleased to announce...
LSL Pharma Group Announces Engagement of Red Cloud Securities
June 11, 2024 07:00 ET
|
LSL Pharma Group Inc.
LSL PHARMA GROUP ANNOUNCES ENGAGEMENT OF RED CLOUD SECURITIES
LSL Pharma Group Announces a Combination of Private Placements for Maximum Aggregate Gross Proceeds of $4.5 Million
June 05, 2024 07:00 ET
|
LSL Pharma Group Inc.
Up to $3.0 M in cash proceedsUp to $1.5 M in debts conversion BOUCHERVILLE, Quebec, June 05, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL) (the "Corporation" or "LSL Pharma "), a...
LSL Pharma Group Reports Record Revenues and Margins for the First Quarter 2024
May 30, 2024 07:00 ET
|
LSL Pharma Group Inc.
LSL Pharma Group Q1 results
LSL Pharma Group Announces Listing of Convertible Redeemable Debentures on the TSXV
May 22, 2024 07:00 ET
|
LSL Pharma Group Inc.
BOUCHERVILLE, Quebec, May 22, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL) (the "Corporation" or "LSL Pharma "), a Canadian integrated pharmaceutical company, is pleased to announce...
LSL Pharma Group Enters Into Binding Agreement to Acquire Quebec Competitor
May 06, 2024 07:00 ET
|
LSL Pharma Group Inc.
Binding agreement to acquire Quebec competitor
LSL Pharma Group Reports Its Fourth Quarter and Year-End 2023 Results and Highlights
April 30, 2024 07:00 ET
|
LSL Pharma Group Inc.
FY-2023 Revenues increased by 22% at $10.0 million compared to $8.2 million for FY-2022, a $1.8 million increase.Gross margins for FY-2023 up $3.8 million compared to FY-2022Net loss for FY-2023 of...
LSL Pharma Group Secures $3.8 Million as the Second and Final Tranche of Its Private Placement of Units
April 24, 2024 07:00 ET
|
LSL Pharma Group Inc.
BOUCHERVILLE, Quebec, April 24, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL) (the "Corporation" or "LSL Pharma"), a Canadian integrated pharmaceutical company, today announced the...